Dr. Meredith Ann McKean, MD
- Medicare services, 2024
- 14,226
- Medicare patients, 2024
- 301
- Part D claims, 2024
- 246
- Publications
- 25
- Clinical trials
- 11
- Practice address
- 201 Franklin Rd, Brentwood, TN 37027
- Practice phone
- Call (615) 329-7640
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nashville Oncology Associates
Brentwood, Tennessee
Find Dr. McKean's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Meredith Ann McKean is a hematologist and oncologist in Brentwood, Tennessee
Dr. McKean practices at Nashville Oncology Associates in Brentwood, Tennessee.
Dr. McKean's NPI, 1437425659, was assigned on April 2, 2012. Dr. McKean graduated from University of Iowa, RJ & L Carver College of Medicine in 2012. Dr. McKean holds Tennessee license 57749.
- NPI
- 1437425659NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5991930745
- NPI enumeration date
- April 2, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (615) 329-7640
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 40
- Medical school graduation
- 2012
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Meredith Ann McKean practices at Nashville Oncology Associates in Brentwood, Tennessee
Dr. McKean's primary practice is Nashville Oncology Associates, at 201 Franklin Rd, Brentwood, TN 37027 in Williamson County. The practice phone is (615) 329-7640.
- Nashville Oncology Associates201 Franklin Rd, Brentwood, TN 37027 · Williamson CountyPhone(615) 329-7640
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Meredith Ann McKean is affiliated with 8 sites of care and 2 medical groups
Dr. McKean's primary practice is Nashville Oncology Associates in Brentwood, Tennessee. Dr. McKean is also affiliated with TriStar Centennial Medical Center. The medical group on file is Nashville Oncology Associates, PC. Dmand AI also links Dr. McKean to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Meredith Ann McKean's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKean practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nashville Oncology Associates | Available with a free account |
| +7 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Meredith Ann McKean is one of 271 hematologists and oncologists in Tennessee
Hematology and oncology is Dr. McKean's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. McKean's licenses on file in 2 states: Tennessee and Texas.
Specialties and state licenses
- Hematology and oncology, TennesseePrimary
- Internal medicine, Texas
Hematologists and oncologists near Dr. McKean
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Meredith Ann McKean billed Medicare for 14,226 services in 2024
CMS data shows 14,226 Medicare services from Dr. McKean across 29 procedure codes in 2024, for 301 Medicare patients. Medicare paid $578,626 for them.
Dr. McKean's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 1,2222024: 11,299825%
- Lab and pathology
- 2023: 1,8632024: 99247%
- Office and hospital visits
- 2023: 6112024: 70916%
- Tests and treatments
- 2023: 7332024: 6718%
- Surgery
- 2023: 2442024: 555127%
Where Dr. McKean's Medicare services took place, 2024
- In an office14,12799%
- In a facility991%
Dr. McKean compared with the Tennessee median for hematologists and oncologists, 2024
- Dr. McKean
- Tennessee median
- Medicare services
- 14,226vs 81817.4 times
- Medicare patients
- 301vs 287Close to median
- Part D claims
- 60vs 50888% below
Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.
Dr. McKean's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. McKean?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McKean and other hematologists and oncologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Meredith Ann McKean treated 301 Medicare patients in 2024, average age 72
CMS counts 301 Medicare patients who saw Dr. McKean in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. McKean's median patient age at 68, with 53% women.
Dr. McKean's Medicare patients by age, 2024
Dr. McKean's Medicare patients by sex, 2024
- Women15752%
- Men14448%
Chronic conditions among Dr. McKean's Medicare patients, 2024
- High blood pressure75%
- High cholesterol66%
- Cancer47%
- Arthritis45%
- Anxiety30%
- Diabetes30%
- Mood disorders28%
- Ischemic heart disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. McKean's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women53%
- Men46%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Meredith Ann McKean wrote 246 Medicare Part D claims in 2024
In 2024, Dr. McKean wrote 246 Medicare Part D claims for 69 patients. 80% of them were for generic drugs. CMS names the drug for 60 of them, across 4 drugs with 11 or more claims each, at $1,010 in total drug cost. In 2023, CMS named 103 claims across 7 drugs.
Dr. McKean's Part D claims by kind of drug, 2024
- Generic196 claims80%
- Brand-name and other50 claims20%
Dr. McKean's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. McKean's Part D claims, 2024
- Opioids11%26 of 246 claims
- Antibiotics9%21 of 246 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1032024: 6042%
Drugs named by CMS: 4 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Meredith Ann McKean scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. McKean for performance year 2024, reported as part of a group. Dr. McKean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKean as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. McKean's MIPS scores, performance year 2024
- 93of 100Final score
- 84.2of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Meredith Ann McKean has 25 publications on record
Dmand AI links 25 papers to Dr. McKean, published from 2016 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Melanoma, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal, Humanized. Dr. McKean has published most often in J Immunother Cancer. Dr. McKean's most frequent co-authors are Timothy J. Panella, MD, Rodabe N. Amaria, MD and Zeynep Eroglu, MD.
Dr. McKean's papers by year, 2016 to 2025
Topics Dr. McKean writes about most
- Melanoma
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal, Humanized
- Skin Neoplasms
- Uveal Melanoma
- Uveal Neoplasms
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
Dr. McKean's most frequent co-authors
- Timothy J. Panella, MD3 shared papers
- Rodabe N. Amaria, MD2 shared papers
- Zeynep Eroglu, MD2 shared papers
Recent publications by Dr. McKean
Pigment Cell Melanoma Res
See who Dr. McKean researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McKean works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Meredith Ann McKean has worked on 11 clinical trials
Dmand AI links Dr. McKean to 11 clinical trials, 5 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Krukenberg Tumor and Melanoma. Open Payments lists research payments to Dr. McKean that name 2 trials.
Clinical trials with Dr. McKean by phase
- 1Phase 1: 1 trial
- 5Phase 1/2: 5 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. McKean's trials
- Prostatic Neoplasms
- Krukenberg Tumor
- Melanoma
- Neurofibrosarcoma
- Prostatic Neoplasms, Castration-Resistant
Investigators on the most trials with Dr. McKean
- Edward R. Arrowsmith, MD2 shared trials
- Michael Joseph Demeure, MD2 shared trials
- Jeremy C. Jones, MD2 shared trials
Recent clinical trials with Dr. McKean
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies (opens in a new tab)
XTX202 in Patients With Advanced Solid Tumors (opens in a new tab)
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (opens in a new tab)
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Meredith Ann McKean received $116,652 in industry payments from 2016 to 2025
CMS Open Payments shows 401 general payments to Dr. McKean from 62 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $53,283. It also lists 84 research payments totaling $44,990 from 2018 to 2025, naming 2 clinical trials.
General payments to Dr. McKean by program year, 2016 to 2025
General payments to Dr. McKean by kind, 2016 to 2025
- Consulting fees$76,65166%
- Travel and lodging$24,64921%
- Food and beverage$10,2819%
- Speaker and faculty fees$4,4104%
- Other$6621%
Companies that paid Dr. McKean the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Meredith Ann McKean graduated from University of Iowa, RJ & L Carver College of Medicine
Dr. McKean graduated from University of Iowa, RJ & L Carver College of Medicine in 2012.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Meredith Ann McKean's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Meredith Ann McKean
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Meredith Ann McKean's NPI number?
Dr. Meredith Ann McKean's NPI number is 1437425659. It was assigned on April 2, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Meredith Ann McKean?
Dr. Meredith Ann McKean is a hematologist and oncologist in Brentwood, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Meredith Ann McKean practice?
Dr. McKean practices at 201 Franklin Rd, Brentwood, TN 37027. Dr. McKean's primary practice is Nashville Oncology Associates in Brentwood, Tennessee. Dmand AI also links Dr. McKean to 4 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Meredith Ann McKean's office phone number?
The practice phone on file for Dr. McKean is (615) 329-7640.
What is Dr. Meredith Ann McKean's medical license number?
Dr. McKean holds Tennessee license 57749, one of the licenses on file in 2 states.
Which states has Dr. Meredith Ann McKean been licensed in?
Dmand AI has state licenses on file for Dr. McKean in Tennessee and Texas.
Which hospitals is Dr. Meredith Ann McKean affiliated with?
Dr. McKean is affiliated with TriStar Centennial Medical Center. Dmand AI links Dr. McKean to 4 more hospitals.
What medical group is Dr. Meredith Ann McKean part of?
Dr. McKean is linked to Nashville Oncology Associates, PC. Dmand AI links Dr. McKean to 1 more medical group.
Does Dr. Meredith Ann McKean accept Medicare?
Yes. CMS data shows Dr. McKean billed Medicare for 14,226 services in 2024, and Dr. McKean accepts Medicare assignment.
Does Dr. Meredith Ann McKean offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. McKean as offering telehealth services.
Show 9 more questionsShow fewer questions
What is Dr. Meredith Ann McKean's MIPS score?
Dr. McKean's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
How many Medicare patients does Dr. Meredith Ann McKean see?
CMS counts 301 Medicare patients who saw Dr. McKean in 2024, with an average age of 72.
What services does Dr. Meredith Ann McKean bill to Medicare?
In 2024, Dr. McKean's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J1100) and surgery: heart and blood vessels (36415).
Where did Dr. Meredith Ann McKean go to medical school?
Dr. McKean graduated from University of Iowa, RJ & L Carver College of Medicine in 2012.
What drugs does Dr. Meredith Ann McKean prescribe most?
In 2024 Medicare Part D data, Dr. McKean's most prescribed drugs by claims were Prednisone, Dexamethasone and Prochlorperazine Maleate.
Has Dr. Meredith Ann McKean received payments from drug or device companies?
CMS Open Payments shows $116,652 in general payments to Dr. McKean from 62 companies from 2016 to 2025. The largest total came from Regeneron Pharmaceuticals, Inc.
How long has Dr. Meredith Ann McKean been practicing?
Dr. McKean graduated from medical school in 2012, 14 years ago.
Does Dr. Meredith Ann McKean do research?
Dmand AI links 25 publications to Dr. McKean, published from 2016 to 2025. Dr. McKean has worked on 11 clinical trials.
Who does Dr. Meredith Ann McKean publish with?
Dr. McKean's most frequent co-authors are Timothy J. Panella, MD (3 shared papers), Rodabe N. Amaria, MD (2 shared papers) and Zeynep Eroglu, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card